Literature DB >> 26265304

Excitatory orexinergic innervation of rat nucleus incertus--Implications for ascending arousal, motivation and feeding control.

Anna Blasiak1, Marcin Siwiec2, Agnieszka Grabowiecka2, Tomasz Blasiak2, Anna Czerw2, Ewa Blasiak3, Alan Kania2, Zenon Rajfur4, Marian H Lewandowski2, Andrew L Gundlach5.   

Abstract

Orexin/hypocretin peptides play a central role in the integrated control of feeding/reward and behavioural activation, principally via interactions with other neural systems. A brainstem area involved in behavioural activation is the nucleus incertus (NI), located in the posterior ventromedial central grey. Several studies have implicated NI in control of arousal/stress and reward/feeding responses. Orexin receptor mRNA expression identifies NI as a putative target of orexin modulation. Therefore, in this study we performed neural tract-tracing and immunofluorescence staining to characterise the orexinergic innervation of NI. Our results indicate a convergent innervation of the NI area by different orexin neuron populations, with an abundance of orexin-A-containing axons making putative synaptic contacts with relaxin-3-positive NI neurons. The influence of orexin-A on NI neuron activity was investigated using patch-clamp recordings. Orexin-A depolarised the majority (64%) of recorded neurons and this effect was maintained in the presence of tetrodotoxin and glutamate and GABA receptor antagonists, indicating a likely postsynaptic action. Voltage-clamp experiments revealed that in 'type I' NI neurons comprising relaxin-3-positive cells, orexin-A acted via L-type calcium channels, whereas in 'type II' relaxin-3-negative neurons, activation of a sodium/calcium exchanger was involved. A majority of the orexin-A sensitive neurons tested for the presence of orexin receptor mRNA, were OX2 mRNA-positive. Immunohistochemical staining for putative orexin receptors on NI neurons, confirmed stronger expression of OX2 than OX1 receptors. Our data demonstrate a strong influence of orexin-A on NI neurons, consistent with an important role for this hypothalamic/tegmental circuit in the regulation of arousal/vigilance and motivated behaviours.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  4- aminopyridine (PubChem CID 1727); Arousal; Bicuculline methiodide (PubChem CID 104871); CNQX disodium salt (PubChem CID 6093155); DL-AP5 (PubChem CID 1216); In vitro electrophysiology; Motivated behaviours; Neural tract-tracing; Nickel (II) chloride (PubChem CID 24385); Nifedipine (PubChem CID: 4485); Orexin-A (PubChem CID: 56842143); Orexin/OX(1/2); Relaxin-3/RXFP3; Tetrodotoxin citrate (PubChem CID: 16759596)

Mesh:

Substances:

Year:  2015        PMID: 26265304     DOI: 10.1016/j.neuropharm.2015.08.014

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  15 in total

Review 1.  Sex-specific effects of relaxin-3 on food intake and body weight gain.

Authors:  Juliane Calvez; Camila de Ávila; Elena Timofeeva
Journal:  Br J Pharmacol       Date:  2016-07-13       Impact factor: 8.739

Review 2.  Dual-transmitter systems regulating arousal, attention, learning and memory.

Authors:  Sherie Ma; Balázs Hangya; Christopher S Leonard; William Wisden; Andrew L Gundlach
Journal:  Neurosci Biobehav Rev       Date:  2017-07-27       Impact factor: 8.989

3.  Inhibition of oxytocin and vasopressin neuron activity in rat hypothalamic paraventricular nucleus by relaxin-3-RXFP3 signalling.

Authors:  Alan Kania; Anna Gugula; Agnieszka Grabowiecka; Camila de Ávila; Tomasz Blasiak; Zenon Rajfur; Marian H Lewandowski; Grzegorz Hess; Elena Timofeeva; Andrew L Gundlach; Anna Blasiak
Journal:  J Physiol       Date:  2017-02-27       Impact factor: 5.182

Review 4.  Modulation of forebrain function by nucleus incertus and relaxin-3/RXFP3 signaling.

Authors:  Francisco E Olucha-Bordonau; Héctor Albert-Gascó; Francisco Ros-Bernal; Valeria Rytova; Emma K E Ong-Pålsson; Sherie Ma; Ana M Sánchez-Pérez; Andrew L Gundlach
Journal:  CNS Neurosci Ther       Date:  2018-05-02       Impact factor: 5.243

5.  Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats.

Authors:  Steven J Simmons; Rose Martorana; Helene Philogene-Khalid; Fionya H Tran; Taylor A Gentile; Xinyan Xu; Shu Su; Scott M Rawls; John W Muschamp
Journal:  Psychopharmacology (Berl)       Date:  2017-08-07       Impact factor: 4.530

Review 6.  Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.

Authors:  Sherie Ma; Craig M Smith; Anna Blasiak; Andrew L Gundlach
Journal:  Br J Pharmacol       Date:  2016-12-04       Impact factor: 8.739

Review 7.  Orexin/hypocretin and dysregulated eating: Promotion of foraging behavior.

Authors:  Jessica R Barson
Journal:  Brain Res       Date:  2018-08-17       Impact factor: 3.252

Review 8.  Medications for alcohol use disorders: An overview.

Authors:  Mohammed Akbar; Mark Egli; Young-Eun Cho; Byoung-Joon Song; Antonio Noronha
Journal:  Pharmacol Ther       Date:  2017-12-02       Impact factor: 12.310

9.  Multiple excitatory actions of orexins upon thalamo-cortical neurons in dorsal lateral geniculate nucleus - implications for vision modulation by arousal.

Authors:  Lukasz Chrobok; Katarzyna Palus-Chramiec; Anna Chrzanowska; Mariusz Kepczynski; Marian Henryk Lewandowski
Journal:  Sci Rep       Date:  2017-08-09       Impact factor: 4.379

Review 10.  Interactions of Circadian Rhythmicity, Stress and Orexigenic Neuropeptide Systems: Implications for Food Intake Control.

Authors:  Anna Blasiak; Andrew L Gundlach; Grzegorz Hess; Marian H Lewandowski
Journal:  Front Neurosci       Date:  2017-03-20       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.